Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 4425813)

Published in Microb Ecol Health Dis on May 07, 2015

Authors

Richard E Frye1,2, Shannon Rose1,3, John Slattery1,3, Derrick F MacFabe4

Author Affiliations

1: Autism Research Program, Arkansas Children's Hospital Research Institute, Little Rock, AR, USA.
2: Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA; REFrye@uams.edu.
3: Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
4: Kilee Patchell-Evans Autism Research Group, Division of Developmental Disabilities, Departments of Psychology and Psychiatry, University of Western Ontario, London, ON, Canada.

Articles citing this

Approaches to studying and manipulating the enteric microbiome to improve autism symptoms. Microb Ecol Health Dis (2015) 0.89

Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes. Clin Med Insights Pediatr (2016) 0.82

New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome (2017) 0.79

Pentadecanoic and Heptadecanoic Acids: Multifaceted Odd-Chain Fatty Acids. Adv Nutr (2016) 0.77

Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access (2016) 0.76

The Pivotal Role of Aldehyde Toxicity in Autism Spectrum Disorder: The Therapeutic Potential of Micronutrient Supplementation. Nutr Metab Insights (2016) 0.76

The potential role of nitrous oxide in the etiology of autism spectrum disorder. Transl Psychiatry (2016) 0.75

Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches. Front Mol Neurosci (2017) 0.75

Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines. Transl Psychiatry (2016) 0.75

A Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis. Sci Rep (2016) 0.75

Introduction. Microb Ecol Health Dis (2015) 0.75

Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb Ecol Health Dis (2016) 0.75

Tryptophan status in autism spectrum disorder and the influence of supplementation on its level. Metab Brain Dis (2017) 0.75

Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias: A hypothesis. Bioessays (2017) 0.75

Articles cited by this

(truncated to the top 100)

Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ (2014) 11.24

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44

Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 8.11

Host-gut microbiota metabolic interactions. Science (2012) 7.73

Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A (2011) 6.16

Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem (2003) 4.79

Gastrointestinal abnormalities in children with autistic disorder. J Pediatr (1999) 2.96

Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis (2002) 2.80

Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev (2012) 2.76

The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res (2013) 2.67

Biochemical assays of respiratory chain complex activity. Methods Cell Biol (2007) 2.56

Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol (2000) 2.50

Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol (2006) 2.49

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry (2011) 2.28

Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol (2005) 2.18

Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol (2004) 2.17

The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab (2008) 2.13

Mitochondrial dysfunction in autism. JAMA (2010) 2.04

Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol (2011) 1.94

Valproic acid-induced pancreatitis: 16 new cases and a review of the literature. J Gastroenterol (2007) 1.88

Defects in mitochondrial DNA replication and human disease. Crit Rev Biochem Mol Biol (2011) 1.86

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry (2011) 1.85

Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta (2010) 1.85

The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis (2004) 1.75

Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One (2011) 1.74

Cyclic vomiting syndrome and mitochondrial DNA mutations. Lancet (1997) 1.69

On the mechanism of action of the antifungal agent propionate. Eur J Biochem (2004) 1.69

Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med (2013) 1.69

Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet (2004) 1.66

L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology (2005) 1.63

Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet (2009) 1.61

Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med (2014) 1.60

Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res (2006) 1.59

5q14.3 deletion manifesting as mitochondrial disease and autism: case report. J Child Neurol (2010) 1.56

The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann Neurol (2001) 1.53

Could one of the most widely prescribed antibiotics amoxicillin/clavulanate "augmentin" be a risk factor for autism? Med Hypotheses (2005) 1.51

Carnitine, valproate, and toxicity. J Child Neurol (1991) 1.49

Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet (2001) 1.47

Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey. Autism (2008) 1.45

Alpers-Huttenlocher syndrome. Pediatr Neurol (2013) 1.44

Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells. Sci Transl Med (2013) 1.43

Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics (2012) 1.41

Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol (2000) 1.41

Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics (2013) 1.36

Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther (2000) 1.36

Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry (2012) 1.35

Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis (2012) 1.35

Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder. Behav Brain Res (2010) 1.33

Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci (2014) 1.31

Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry (2014) 1.30

Acute management of propionic acidemia. Mol Genet Metab (2011) 1.30

Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol (2003) 1.30

Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain (2010) 1.28

Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry (2008) 1.27

Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord (2014) 1.26

Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet (2006) 1.26

In utero exposure to valproic acid and autism--a current review of clinical and animal studies. Neurotoxicol Teratol (2013) 1.25

Microbiology of regressive autism. Anaerobe (2011) 1.24

Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res (2011) 1.24

Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem (2011) 1.24

Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One (2013) 1.24

Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology (2008) 1.23

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut (2014) 1.23

Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry (2012) 1.22

Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS One (2014) 1.20

Early medical history of children with autism spectrum disorders. J Dev Behav Pediatr (2006) 1.20

Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia (2007) 1.19

Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia (2009) 1.18

Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl Psychiatry (2013) 1.17

Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Altern Complement Med (2004) 1.15

Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study. BMC Neurol (2010) 1.15

Bioremediation and tolerance of humans to heavy metals through microbial processes: a potential role for probiotics? Appl Environ Microbiol (2012) 1.15

ADHD and autism: differential diagnosis or overlapping traits? A selective review. Atten Defic Hyperact Disord (2012) 1.14

Extended shelf life of soy bread using modified atmosphere packaging. J Food Prot (2006) 1.14

Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin. Infect Immun (2003) 1.14

Adverse drug reactions induced by valproic acid. Clin Biochem (2013) 1.14

Recent developments in the investigation of inherited metabolic disorders using cultured human cells. Mol Genet Metab (1999) 1.13

Are pediatric and adult-onset cyclic vomiting syndrome (CVS) biologically different conditions? Relationship of adult-onset CVS with the migraine and pediatric CVS-associated common mtDNA polymorphisms 16519T and 3010A. Neurogastroenterol Motil (2009) 1.12

Specialized metabolites from the microbiome in health and disease. Cell Metab (2014) 1.12

Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics (2014) 1.12

Short chain fatty acids dilate isolated human colonic resistance arteries. Gut (1990) 1.12

Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol (2009) 1.12

Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl Psychiatry (2014) 1.11

A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry (1993) 1.11

The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell Microbiol (2005) 1.11

Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr (1999) 1.10

Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Res (2011) 1.09

Oxidative shielding or oxidative stress? J Pharmacol Exp Ther (2012) 1.09

Drugs interfering with mitochondrial disorders. Drug Chem Toxicol (2010) 1.09

Changes in gastrointestinal morphology associated with obstructive jaundice. J Pathol (2000) 1.07

Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology (2010) 1.07

Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav Brain Res (2008) 1.06

Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot Essent Fatty Acids (2009) 1.06

Toward effective probiotics for autism and other neurodevelopmental disorders. Cell (2013) 1.06

Metabolic features of the cell danger response. Mitochondrion (2013) 1.05

Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats. World J Gastroenterol (2003) 1.05

Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr (2011) 1.05

Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis (2013) 1.04

Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res (2014) 1.04

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol (2014) 1.04

Articles by these authors

Introduction. Microb Ecol Health Dis (2015) 0.75